Detection of tau spatial extent using MK6240 and flortaucipir PET
INTRODUCTION: Tau PET enables in vivo quantification of neurofibrillary tangle spread, yet whether tau spatial extent (TSE) performs comparably across tracers remains unknown. METHODS: We performed a head-to-head comparison of Flortaucipir and MK6240 tau PET in 682 individuals across the AD continuum, quantifying TSE as the percentage of regional voxels exceeding a tracer-specific abnormality threshold and evaluated it as a metric of tracer comparability. RESULTS: MK6240 showed greater TSE than Flortaucipir (CU Aβ+, medial temporal lobe [MTL]: 42% vs 25%; dementia Aβ+, late neocortical: 55% vs 42%), reaching 50% detection probability at lower Aβ burden (Centiloid: MTL, 26 vs 45; late neocortical, 95 vs 118). TSE showed higher associations than SUVR with memory, Aβ PET, and plasma pTau217, particularly in the neo-late composite. Participants with intermediate tau involvement (TSE 25–50%), most below the SUVR positivity thresholds (MTL positivity 10.2–16.9%), had approximately three-fold higher odds of Aβ PET and pTau217 positivity than TSE 0-25% (ORs 2.90–3.46). 53.4% of intermediate Flortaucipir cases (TSE 25–50%) shifted to a higher MK6240 category, and 82.5% of moderately high Flortaucipir cases (50–75%) were classified as near-saturated (75–100%) by MK6240. Neither raw TSE nor raw SUVR was directly interchangeable across tracers, with systematic and proportional bias for both metrics (MTL Deming slope: TSE 1.29; SUVR 2.69). DISCUSSION: TSE showed stronger unadjusted associations than SUVR in selected region- and outcome-specific comparisons, supporting its potential as a complementary measure. Like SUVR, raw TSE values were not directly interchangeable between flortaucipir and MK6240, and tracer-specific calibration and validation are required before cross-tracer use.
Authors
- Val J. Lowe (ORCID: https://orcid.org/0000-0002-5612-1667)
- Dana Tudorascu (ORCID: https://orcid.org/0000-0003-4675-3692)
- Tharick Ali Pascoal (ORCID: https://orcid.org/0000-0001-9057-8014)
- Marina Scop Medeiros (ORCID: https://orcid.org/0009-0009-4237-4565)
- Juan Fortea (ORCID: https://orcid.org/0000-0002-1340-638X)
- Guilherme Povala (ORCID: https://orcid.org/0000-0002-2023-6569)
- Douglas Teixeira Leffa (ORCID: https://orcid.org/0000-0002-4890-8451)
- Belén Pascual (ORCID: https://orcid.org/0000-0002-4467-7406)
- Joseph C. Masdeu (ORCID: https://orcid.org/0000-0001-9955-6954)
- Guilherme Bauer‐Negrini (ORCID: https://orcid.org/0000-0003-0956-557X)
- Pâmela C.L. Ferreira (ORCID: https://orcid.org/0000-0003-2134-9829)
- Emma Patrice Ruppert (ORCID: https://orcid.org/0000-0001-5877-5472)
- Arthur C. Macedo (ORCID: https://orcid.org/0000-0002-3957-0284)
- Thomas K. Karikari (ORCID: https://orcid.org/0000-0003-1422-4358)
- Bruna Bellaver (ORCID: https://orcid.org/0000-0002-2212-3373)
- David N. Soleimani‐Meigooni (ORCID: https://orcid.org/0000-0003-4197-3039)
- Suzanne L. Baker (ORCID: https://orcid.org/0000-0003-0209-3127)
- Firoza Zubeida Lussier (ORCID: https://orcid.org/0000-0002-6877-4825)
- Lívia Amaral (ORCID: https://orcid.org/0009-0005-4488-763X)
- Cécile Tissot (ORCID: https://orcid.org/0000-0003-2711-3833)
- Brian Andrew Gordon (ORCID: https://orcid.org/0000-0003-2109-2955)
- Pedro Rosa‐Neto (ORCID: https://orcid.org/0000-0001-9116-1376)
- Hwamee Oh (ORCID: https://orcid.org/0000-0003-1156-5704)
- the HEAD Study
Institutions
- Houston Methodist (US)
- Lawrence Berkeley National Laboratory (US)
- University of Pittsburgh (US)
- John Brown University (US)
- University of California, San Francisco (US)
- Washington University in St. Louis (US)
- Hospital de Sant Pau (ES)
- Mayo Clinic in Arizona (US)
- Institut de Recerca Sant Pau (ES)
- UCSF Edward and Pearl Fein Memory and Aging Center (US)
- Houston Methodist Research Institute (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-10-28
- DOI
- https://doi.org/10.64898/2026.10.26.26366488
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- preprint
Funders
- Alzheimer's Association
- Weston Brain Institute
- Fundación Tatiana Pérez de Guzmán el Bueno
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Canadian Institutes of Health Research
- European Regional Development Fund
- National Institute on Aging